Search

everythinglearnresearchcommunity

for

Search:↓

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

The HCR gene contributes to psoriasis risk.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Citrate is a safer alternative to heparin for preventing blood clots in hemodialysis.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

A man with lung cancer had skin and eye side effects from erlotinib but continued treatment with symptom improvement.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

A small change in the TRPS1 gene leads to a less severe form of a syndrome affecting hair, nose, and finger development.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

Pexidartinib often causes liver issues and fatigue, especially in women.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Cladribine has known risks and potential new safety concerns, requiring careful monitoring.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Retinoids may help treat lupus nephritis and reduce steroid use.